The global animal biotechnology market is undergoing a rapid transformation. With a market size projected to rise from USD 30.97 billion in 2025 to USD 72.6 billion by 2034, this sector is booming at a CAGR of 9.93%. The shift toward ethical practices, sustainable technologies, and transparency in animal production is fueling innovation across veterinary care, animal agriculture, and biomedical research.

This article dives into the market’s current landscape, key trends, strategic directions, and highlights top companies driving the animal biotechnology revolution.

---

📈 Animal Biotechnology Market Overview

• 2024 Market Size: USD 28.17 Billion

• 2025 Projection: USD 30.97 Billion

• 2034 Projection: USD 72.6 Billion

• Growth Rate: 9.93% CAGR (2025–2034)

• Regional Leader (2024): North America

• Fastest Growing Region: Asia Pacific

• Leading Product Segment: Vaccines

• Fastest Growing Product Segment: Genetic Engineering

• Top Application: Animal Health

---

🏢 Top Companies in the Animal Biotechnology Market

1. Zoetis Inc.

• About: A global leader in animal health, Zoetis specializes in medicines, vaccines, and diagnostics for livestock and pets.

• Key Products: Simparica, Draxxin, Vanguard vaccines.

• Market Cap: Approx. USD 80+ billion.

2. Merck Animal Health

• About: A division of Merck & Co., it delivers innovative solutions to enhance animal well-being.

• Key Products: Bovilis, Bravecto, Nobivac.

• Market Cap (Parent): Approx. USD 320+ billion.

3. Elanco Animal Health

• About: Focuses on pet health and livestock sustainability, including the acquisition of Bayer Animal Health.

• Key Products: Trifexis, Galliprant, Credelio.

• Market Cap: Approx. USD 7+ billion.

4. Boehringer Ingelheim Animal Health

• About: Part of Boehringer Ingelheim, it prioritizes preventive animal health and innovation in vaccines.

• Key Products: NexGard, Ingelvac CircoFLEX.

• Market Cap (Privately Held): Estimated USD 60–70 billion range.

5. Ceva Santé Animale

• About: A global veterinary pharmaceutical group with a strong emphasis on research and biotech innovation.

• Key Products: Vectormune, Cevac, Feliway.

• Market Cap: Estimated revenue of USD 1.5+ billion.

6. Virbac

• About: A France-based company focused on companion animal health with a strong global presence.

• Key Products: Effipro, Canigen, CaniLeish.

• Market Cap: Approx. USD 2.5+ billion.

7. Vetoquinol

• About: A family-owned veterinary pharmaceutical company operating in 24 countries.

• Key Products: Marbocyl, Clavaseptin, Zentonil.

• Market Cap: Approx. USD 1+ billion.

8. IDEXX Laboratories

• About: A pioneer in veterinary diagnostics, software, and water microbiology testing.

• Key Products: SNAP Pro Analyzer, VetLab Station.

• Market Cap: Approx. USD 40+ billion.

9. Thermo Fisher Scientific

• About: A science services giant, offering biotechnology tools including for animal health applications.

• Key Products: PCR kits, VetMAX assays.

• Market Cap: Approx. USD 200+ billion.

10. IDEXX BioAnalytics

• About: A branch of IDEXX, offering lab testing and genetic analysis for animal health research.

• Key Services: Pathogen testing, genetic monitoring.

• Market Cap: Part of IDEXX Laboratories.

11. Genus PLC

• About: A UK-based company focusing on animal genetic improvement and livestock biotech.

• Key Products: Genus PIC, ABS Global breeding services.

• Market Cap: Approx. USD 2.5+ billion.

12. Neogen Corporation

• About: Provides food and animal safety solutions, including DNA testing for livestock.

• Key Products: Igenity, Reveal for Mycotoxins.

• Market Cap: Approx. USD 4+ billion.

13. BioChek

• About: Specializes in veterinary diagnostic tools, particularly ELISA and PCR for poultry and swine.

• Key Products: Infectious disease testing kits.

• Market Cap: Private company (financials undisclosed).

14. Bio-Rad Laboratories

• About: Offers life science tools, including diagnostics applicable in animal health.

• Key Products: ELISA kits, qPCR systems.

• Market Cap: Approx. USD 12+ billion.

15. Recombinetics Inc.

• About: Innovator in gene editing technologies for livestock and biomedical models.

• Key Focus: Gene-edited pigs for medical research.

• Market Cap: Private company (estimated < USD 500 million).

If you have any questions, please feel free to contact us at sales@towardshealthcare.com

---

❓ Frequently Asked Questions (FAQs)

1. What is animal biotechnology?

Animal biotechnology involves the use of genetic, cellular, and molecular technologies to improve animal health, reproduction, and productivity, often through vaccines, diagnostics, and genetic engineering.

2. Which region is leading the animal biotechnology market?

North America led the market in 2024, driven by advanced veterinary infrastructure and high R&D investment.

3. What are the fastest-growing segments?

The genetic engineering product type and the Asia Pacific region are projected to witness the fastest growth rates.

4. Why is the market growing rapidly?

Factors include rising demand for animal protein, focus on animal welfare, and increasing adoption of advanced veterinary technologies.

5. What are the major applications of animal biotechnology?

Key applications include animal health, transgenic research, genetic engineering for improved livestock, and biomedical research.

Source : https://www.towardshealthcare.com/insights/animal-biotechnology-market-sizing

Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5849